Leading the charge against cancer in Arizona
News
A Shot at Prevention
Vaccines have helped transform our relationship with infectious diseases. In parts of the world with widespread vaccination, fatal illnesses like measles and whooping cough no longer inspire fear. Rather than fretting over microbes, most of us reading this magazine are more concerned about chronic diseases like diabetes, heart disease and cancer. Read More
An Intervention with Heart
Ovarian cancer is relatively rare, striking 1 out of 78 women. But it also is one of the deadliest cancers, with only 44 percent of patients surviving five years past their diagnosis. After their disease goes into remission, many patients worry the cancer will return. Read More
UA Researcher Studying New Treatment to Prolong Survival in Advanced Biliary Tract Cancers
A new treatment that may extend survival for patients with advanced biliary tract cancers — who typically face a grim outlook with average survival of less than a year — is being studied by a University of Arizona Cancer Center researcher. Biliary tract (liver, gallbladder and pancreas) cancers are a rare malignancy with only about 15,000 new cases in the United States each year, said Rachna Shroff, MD, section chief of gastrointestinal medical oncology and leader of the GI Disease-Oriented Team at the UA Cancer Center. Read More
Cancer in Arizona
Patient Stories
Patient Profile: Kristie Kilkelly
For Kristie Kilkelly, knowledge is power. She provides her high school history students with the tools needed to gather knowledge for themselves. She places a high premium on scientific knowledge. And she understands from firsthand experience that self-knowledge can be lifesaving.
Prevention
Research
UA Targeting Rhabdomyosarcoma, a Rare Pediatric Cancer With Few Treatment Options
UA Cancer Center researcher harnesses “big data” to identify targeted treatments for rhabdomyosarcoma, a rare cancer that mostly strikes children and teenagers.
As Dry as the Desert in July
A fleeting nuisance for most, dry mouth can wreak havoc on a head-and-neck cancer survivor’s quality of life
‘Evil’ Proteins Are a Force for Good in Estrogen Receptor-Positive Breast Cancer
University of Arizona Cancer Center researchers clarify questions surrounding estrogen’s role in breast cancer, which could lead to more precise treatments for ER-positive breast cancers.